Ranbaxy Laboratories Limited Stock

Stocks

End-of-day quote NSE India S.E.
- ^INR	-

07/03/16	UCB : Pharma crusader takes India's drug regulators to court	RE
29/06/15	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

07/03/16	UCB : Pharma crusader takes India's drug regulators to court	RE
29/06/15	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
20/04/15	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
31/01/15	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
06/12/14	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
21/11/14	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
19/11/14	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
28/10/14	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
31/07/14	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
26/07/14	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
17/07/14	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
25/06/14	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
19/06/14	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

05/03/15	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
29/01/15	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
06/12/14	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
01/12/14	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
29/07/14	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

17/07/14	Novartis : confirme l'objectif de croissance de ses ventes
17/07/14	Novartis : confirme l'objectif de croissance du C.A. annuel
19/06/14	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
23/04/14	S& 500 : Vague de fusions dans le domaine de la pharmacie
07/04/14	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.45%	+3.13%	+54.96%	+125.16%	1,135B
JOHNSON & JOHNSON	+0.94%	+4.93%	+39.86%	+78.72%	635B
ABBVIE INC.	+0.39%	+1.44%	+25.77%	+97.48%	505B
ROCHE HOLDING AG	+1.43%	+4.31%	+46.20%	+67.12%	378B
MERCK & CO., INC.	-3.21%	-2.10%	+60.72%	+33.22%	358B
NOVARTIS AG	-0.41%	+2.64%	+22.48%	+49.82%	295B
ASTRAZENECA PLC	+0.23%	+3.66%	+2.57%	+23.69%	266B
AMGEN INC.	+1.22%	+4.63%	+52.40%	+64.85%	237B
GILEAD SCIENCES, INC.	+1.70%	+3.67%	+31.21%	+102.15%	193B
Average	+0.27%	+2.79%	+37.35%	+71.36%	444.85B
Weighted average by Cap.	+0.42%	+2.85%	+41.40%	+83.61%

Employees

Sector